• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Vaccines, Blood & Biologics

  • Print
  • Share
  • E-mail
?
-

Resources for You

Hizentra

STN:  BL 125350
Proper Name: Immune Globulin Subcutaneous (Human), 20% Liquid
Tradename: Hizentra
Manufacturer: CSL Behring AG, License #1766
Indication:

  • Treatment of primary immunodeficiency (PI) in adults and pediatric patients 2 years of age and older.

 

 

Contact FDA

(800) 835-4709
(301) 827-1800
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

1401 Rockville Pike

Suite 200N/HFM-47

Rockville, MD 20852-1448